- Apte, M. V., Park, S., Phillips, P. A., Santucci, N., Goldstein, D., Kumar, R. K., & Keogh, G. (2004). Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas, 29(3), 179-187.
- Crnogorac-Jurcevic, T., Efthimiou, E., Capelli, P., Blaveri, E., Baron, A., Terris, B., & Lemoine, N. R. (2001). Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene, 20(50), 7437.
- Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012). The pancreas cancer microenvironment.
- Kalos, M., & June, C. H. (2013). Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. Immunity, 39(1), 49-60.
- Katari, U. L., Keirnan, J. M., Worth, A. C., Hodges, S. E., Leen, A. M., Fisher, W. E., & Vera, J. F. (2011). Engineered T cells for pancreatic cancer treatment. HPB, 13(9), 643-650.
- Korc, M. (2007). Pancreatic cancer–associated stroma production. The American Journal of Surgery, 194(4), S84-S86.
- Lamers, C. H., Sleijfer, S., Van Steenbergen, S., Van Elzakker, P., Van Krimpen, B., Groot, C., & Gratama, J. W. (2013). Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity. Molecular therapy, 21(4), 904-912.
- Morgan, R. A., Yang, J. C., Kitano, M., Dudley, M. E., Laurencot, C. M., & Rosenberg, S. A. (2010). Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Molecular Therapy, 18(4), 843-851.
- Nielsen, M. F. B., Mortensen, M. B., & Detlefsen, S. (2016). Key players in pancreatic cancer-stroma interaction: cancer-associated fibroblasts, endothelial and inflammatory cells. World journal of gastroenterology, 22(9), 2678.
- Rosenberg, S. A., & Restifo, N. P. (2015). Adoptive cell transfer as personalized immunotherapy for human cancer. Science, 348(6230), 62-68.
- Savoldo, B., Ramos, C. A., Liu, E., Mims, M. P., Keating, M. J., Carrum, G., & Liu, H. (2011). CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients. The Journal of clinical investigation, 121(5), 1822-1826.
- Watanabe, K., Luo, Y., Da, T., Guedan, S., Ruella, M., Scholler, J., & Siurala, M. (2018). Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI insight, 3(7).
- Whatcott, C. J., Diep, C. H., Jiang, P., Watanabe, A., LoBello, J., Sima, C., & Han, H. (2015). Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer. Clinical Cancer Research, clincanres-1051.
Pancreatic cancer
Subject: | Health Care |
Type: | Expository Essay |
Pages: | 5 |
Word count: | 1124 |
Topics: | Biology, Cancer, Disease, Genetic Engineering, Health, Medicine |
Sources
More samples
Related Essays
Get a brand-new guide on essay writing
The download will start within seconds. Good luck!
Download Sample
This essay is publicly available.
Offered for reference purposes only.
Offered for reference purposes only.
By clicking Get this Sample you agree to the Terms And conditions and Privacy policy.
Thank you!
The download will start shortly.